logo

Quick Facts

Share

Facebook has hired former UK deputy prime minister Nick Clegg as its head of global affairs and communications. Nick Clegg, who was Britain's deputy prime minister from 2010 to 2015, succeeds Elliot Schrage and will report to Sandberg. The former head of the Liberal Democrats will move to Silicon Valley...

Bristol-Myers Squibb Co. (BMY) today announced follow-up data evaluating Opdivo (nivolumab) monotherapy and Opdivo in combination with Yervoy (ipilimumab) in patients with platinum-pretreated metastatic urothelial carcinoma (mUC). The company noted that the results from the Phase 1/2 CheckMate -032...

BCB Bancorp Inc. (BCBP) Friday reported third-quarter net income of $4.6 million or $0.27 per share, up from $3.2 million or $0.25 per share last year. Net interest income, before the provision for loan losses, increased 28.9 percent to $20.1 million from $15.6 million in the third quarter a year...

AbbVie (ABBV) disclosed in a regulatory filing that William Chase, Executive Vice President, Chief Financial Officer, informed the company that he plans to retire from the company in mid-2019. Effective October 19, 2018, Chase has been appointed Executive Vice President, Finance and Administration,...

Novartis announced Phase II preliminary results of the GEOMETRY mono-1 clinical trial of investigational MET inhibitor capmatinib (INC280) in 94 adult patients with advanced non-small cell lung cancer or NSCLC harboring MET exon-14 skipping mutations. The GEOMETRY mono-1 study showed an overall response...

MorphoSys AG (MOR) said that its licensee Janssen Research & Development, LLC, has announced new long-term data from the open-label-period of the phase 3 VOYAGE 1 clinical trial demonstrating stably maintained rates of skin clearance with Tremfya treatment at week 52 (1 year) and week 156 (3 years) among...

Mylan N.V. (MYL) and Biocon Ltd. said that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab). The positive CHMP opinion is based on data submitted as...

AstraZeneca (AZN.L, AZN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending the marketing authorisation for Bevespi Aerosphere in a pressurised metered-dose inhaler as a maintenance dual bronchodilator...

NuVasive Inc. (NUVA) said that it appointed Christopher Barry to succeed Gregory Lucier as chief executive officer effective November 5, 2018. Barry will join the NuVasive Board of Directors; Lucier will continue to serve as chairman of the Board. The company also announced that Matt Link, currently...

Shire plc (SHP.L, SHPG) announced the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of marketing authorisation of lanadelumab injection for routine prevention of recurrent attacks of hereditary angioedema in patients...

French drug giant Sanofi SA (SNYNF, SNY) said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion for the marketing authorization of Sanofi's dengue vaccine, recommending its approval in Europe. The dengue vaccine has...

Lupin Neurosciences, a specialty pharma division of Lupin Ltd, said that the Committee for Medicinal Products for Human Use or CHMP, the scientific committee of the European Medicines Agency or EMA, has adopted a positive opinion recommending the marketing authorization of NaMuscla (mexiletine hydrochloride)...

Sensient Technologies Corp. (SXT) said it now expects that full year adjusted earnings per share will be slightly below the range previously provided. "I am pleased that we have now lapped the aftermath of our restructuring as well as our onion issues, which have impacted the Flavors & Fragrances...

VF Corp. (VFC) announced, for fiscal year 2019, adjusted earnings per share is now expected to be $3.65, reflecting an increase of 16 percent. This compares to the previous expectation of $3.52 to $3.57. Revenue is now expected to be at least $13.7 billion, reflecting an increase of at least 11 percent....

Royal Philips (PHG) announced that its General Meeting of Shareholders appointed Marc Harrison as a member of the company's Supervisory Board with immediate effect. A specialist in pediatric critical care, Dr. Harrison has held leadership positions at Cleveland Clinic - including as CEO of Cleveland...

Follow RTT